Literature DB >> 2960904

Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs.

P D Verdouw1, L M Sassen, D J Duncker, I O Schmeets, R J Rensen, P R Saxena.   

Abstract

The present investigation was conducted to study systemic and regional haemodynamic effects of nicorandil, a potent coronary vasodilator, after intravenous or local intracoronary administration in anaesthetized or conscious pigs. Intravenous infusions of nicorandil for 10 min in both anaesthetized (15, 30, 75 and 150 micrograms.kg-1.min-1) and conscious (20, 40 and 80 micrograms.kg-1.min-1) pigs reduced arterial blood pressure, stroke volume, left ventricular end-diastolic pressure (LVEDP) and systemic vascular resistance, but increased heart rate and maxLVdP/dt. Since nicorandil decreased LVEDP at doses which did not affect arterial blood pressure, the drug may be considered as a more potent venodilator than arterial dilator. Nicorandil increased cardiac output only in conscious animals due to a more marked tachycardia (85% after 80 micrograms.kg-1.min-1) than in anaesthetized animals (30% after 75 micrograms.kg-1.min-1). The nicorandil-induced increase in heart rate and maxLVdP/dt, being substantially attenuated in conscious pigs after treatment with propranolol, can be ascribed to a reflex activation of the sympathetic nervous system following the fall in arterial pressure. Although cardiac output did not change in anaesthetized animals, intravenous infusions of nicorandil did cause a redistribution of blood flow in favour of organs such as the heart, adrenals, spleen, small intestine and brain at the expense of that to the stomach and kidneys; hepatic artery and skeletal muscle blood flow did not change. The increase in myocardial blood flow, primarily to the subepicardial layers, was associated with an enhancement in coronary venous oxygen content and was also notices after intracoronary infusions of nicorandil (0.6, 1.5, 3 and 6 micrograms.kg-1.min-1).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960904     DOI: 10.1007/bf00172690

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation.

Authors:  Y Uchida; N Yoshimoto; S Murao
Journal:  Jpn Heart J       Date:  1978-01

2.  Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances.

Authors:  P R Saxena; H C Schamhardt; R P Forsyth; J Hoeve
Journal:  Comput Programs Biomed       Date:  1980-12

3.  Usefulness of pimobendan in the treatment of heart failure.

Authors:  D J Duncker; F J van Dalen; J M Hartog; J M Lamers; R J Rensen; P R Saxena; P D Verdouw
Journal:  Arzneimittelforschung       Date:  1986-12

4.  Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.

Authors:  K A Lamping; D C Warltier; H F Hardman; G J Gross
Journal:  J Pharmacol Exp Ther       Date:  1984-05       Impact factor: 4.030

5.  Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.

Authors:  H Nakaya; A Schwartz; R W Millard
Journal:  Circ Res       Date:  1983-03       Impact factor: 17.367

6.  Cardiovascular effects of a new coronary vasodilator N-(2-hydroxyethyl)nicotinamide nitrate (SG-75): comparison with nitroglycerin and diltiazem.

Authors:  K Sakai; Y Shiraki; H Nabata
Journal:  J Cardiovasc Pharmacol       Date:  1981 Jan-Feb       Impact factor: 3.105

7.  Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.

Authors:  D C Warltier; M G Zyvoloski; G J Gross; H L Brooks
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

8.  Regional vascular adjustments during recovery from myocardial infarction in rats.

Authors:  H Drexler; E J Toggart; M R Glick; J Heald; S F Flaim; R Zelis
Journal:  J Am Coll Cardiol       Date:  1986-07       Impact factor: 24.094

9.  The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.

Authors:  D J Duncker; J M Hartog; P G Hugenholtz; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

10.  Effects of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) on methacholine-induced ECG changes in intact anesthetized rats.

Authors:  J Aono; M Akima; K Sakai
Journal:  Jpn J Pharmacol       Date:  1981-10
View more
  9 in total

1.  Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.

Authors:  L J van Woerkens; N R Baas; W J van der Giessen; P D Verdouw
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

2.  Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.

Authors:  L M Sassen; D J Duncker; B C Gho; H W Diekmann; P D Verdouw
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

3.  Evidence against a role for dopamine D1 receptors in the myocardium of the pig.

Authors:  L J Van Woerkens; D J Duncker; M O Den Boer; E O McFalls; L M Sassen; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Nicorandil and cardiovascular performance in anaesthetized pigs with a concentric coronary artery stenosis.

Authors:  L M Sassen; L K Soei; T J Heere; L J van Woerkens; P R Saxena; P D Verdouw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

Review 5.  Pharmacology and therapeutic effects of nicorandil.

Authors:  M Kinoshita; K Sakai
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

6.  Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway.

Authors:  Olivier C Manintveld; Maaike te Lintel Hekkert; Elisabeth Keijzer; Pieter D Verdouw; Dirk J Duncker
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

7.  The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.

Authors:  L M Sassen; L K Soei; M M Koning; P D Verdouw
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

8.  Nisoldipine and perfusion of post-stenotic myocardium in conscious pigs with different degrees of concentric stenosis.

Authors:  D J Duncker; J P Heiligers; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

9.  Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease.

Authors:  D Angerbach; C D Nicholson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.